不管最近刚刚获批的晚期RCC的新治疗法如何，大多数对于正在进行的治疗无响应的患者都有着不良的预后。
Despite the recent approval of new therapies for advanced RCC, many patients who do not respond to the existing treatments have a poor prognosis.
有些已经用于癌症治疗，有几种正在进行湿性amd的临床试验，并且看起来很有希望成功。
Some are already used as cancer treatments and several are now in clinical trials for wet AMD, where they look promising.
有关在单纯性疱疹和艾滋病治疗中使用二叔丁基对甲酚(BHT)的研究正在进行中。
Research is underway concerning the use of BHT in the treatment of herpes simplex and AIDS.
应用推荐